Overview

Bowman-Birk Inhibitor Concentrate in Healthy Men

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This randomized phase I trial is studying the side effects and best dose of Bowman-Birk inhibitor concentrate in healthy men. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of Bowman-Birk inhibitor concentrate may prevent cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)